The post-Human Genome Project mindset: Race, reliability, and health care

Clinical Genetics

Volumn 70, Issue 5, 2006, Pages 427-432

  Kimmelman, Jonathan ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Genetic testing; Genetics; Human Genome Project; Hype; Race; Reliability

Indexed keywords

ARTICLE; CLINICAL MEDICINE; GENETIC DIFFERENCE; HEALTH CARE ORGANIZATION; HEALTH CARE SYSTEM; HUMAN; HUMAN GENETICS; HUMAN GENOME PROJECT; MASS COMMUNICATION; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RACE; RELIABILITY; SCIENCE; SOCIAL ASPECT; WORKSHOP;

COMMUNICATION; CONTINENTAL POPULATION GROUPS; DELIVERY OF HEALTH CARE; GENETIC VARIATION; GENETICS, MEDICAL; HUMAN GENOME PROJECT; HUMANS; VARIATION (GENETICS);

EID: 33749454767     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2006.00706.x     Document Type: Article

References (25)

1. Gould SJ. The mismeasure of man. New York: W.W. Norton, 1996.
2. Aronowitz RA. Making sense of illness: Science, society, and disease. New York: Cambridge University Press, 1998.
3. Wynne B. Risk and social learning: Reification to engagement. In: Krimsky S, Golding D, eds. Social theories of risk. Westport: Praeger, 1992: 275-297.
4. Foster MW, Sharp RR. Beyond race: Towards a whole-genome perspective on human populations and genetic variation. Nat Rev Genet 2004: 5: 790-796.
5. Thatcher N, Chang A, Parikh P et al. Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: Results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer). Lancet 2005: 366: 1527-1537.
6. Bouchard EG. The importance of race and ethnic background in biomedical research and clinical practice. N Engl J Med 2003: 348: 1170-1175.
7. Tsurutani J, Ballas M, Steinberg SM et al. Gefitinib for refractory advanced non-small-cell lung cancer. Lancet 2006: 367: 300 (Letter).
8. Risch N, Burchard E, Ziv E et al. Categorization of humans in biomedical research: Genes, race and disease. Genome Biol 2002: 7: 1-12.
9. Sellers WR, Meyerson M. EGFR gene mutations: A call for global × global views of cancer. J Natl Cancer Inst 2005: 97: 326-328.
10. Kitcher P. Science, truth and democracy. New York: Oxford University Press, 2002.
11. Kendler KS. Psychiatric genetics: A methodologic critique. Am J Psychiatry 2005: 162: 3-11.
12. Paul DB. PKU screening: Competing agendas, converging stories. In: The politics of heredity: Essays on eugenics, biomedicine, and the nature-nurture debate. Albany: SUNY Press, 1998: 173-186.
13. Weiss KM. Evolution by phenotype: A biomedical perspective. Perspect Biol Med 2003: 46: 159-182.
14. Levy-Lahad E, Plon SE. A risky business: Assessing breast cancer risk. Science 2003: 302: 574-575.
15. King MC, Marks JH, Mandell JB et al. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003: 302: 643-646.
16. Cooper RS, Kaufman JS, Ward R. Race and Genomics. N Engl J Med 2003: 348: 1166-1170.
17. Creighton S, Almqvist EW, MacGregor D et al. Predictive, pre-natal and diagnostic genetic testing for Huntington's disease: The experience in Canada from 1987 to 2000. Clin Genet 2003: 63: 462-475.
18. Roberts JS, Barber J, Brown TM et al. Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial. Genet Med 2004: 6: 197-203.
19. Marteau TM, Roberts S, LaRusse S et al. Predictive genetic testing for Alzheimer's disease: Impact upon risk perception. Risk Anal 25: 2005: 397-404.
20. Dijk SV, Otten W, Timmermans DR et al. What's the message? Interpretation of an uninformative BRCA1/2 test result for women at risk of familial breast cancer. Genet Med 2005: 7: 239-245.
21. Dorval M, Gauthier G, Maunsell E et al. No evidence of false reassurance among women with an inconclusive BRCA1/2 genetic test result. Cancer Epidemiol Biomarkers Prev 2005: 14: 2862-2867.
22. Gamm JL, Nußbaum RL, Biesecker BB. Genetics and alcoholism among at-risk relatives I: Perceptions of cause, risk, and control. Am J Med Genet 2004: 15: 144-150.
23. Marx K. The 18th Brumaire of Louis Bonaparte. New York: International Publishers, 1963 (originally 1869).
24. Rothman DJ, Rothman SM. The pursuit of perfection: The promise and perils of medical enhancement. New York: Random House, 2003.
25. Pieters T. Interferon: The science and selling of a miracle drug. London: Routledge, 2005.